Anti-GABA-A Receptor Antibody-Mediated Epilepsia Partialis Continua After Treatment With Alemtuzumab: A Case Report.

Dominica RatusznyThomas SkripuletzThomas StüberEmil ValizadaKlaus GehringPhilipp ErtlJörg Andreas MüllerMike P WattjesFriedrich FeuerhakeKurt-Wolfram Sühs

Published in: Neurology(R) neuroimmunology & neuroinflammation (2023)

Our case describes a severe autoantibody-induced encephalitis in a young patient with MS, with alemtuzumab as a potential trigger for anti-GABA-A receptor encephalitis.

Keyphrases

drug induced
high glucose
ms ms
risk assessment
diabetic rats
binding protein
early onset
oxidative stress
human health
middle aged